Subject Completion
Subject completion is when a clinical study participant ceases to be actively engaging in a clinical study because the participant has, or is presumed to have followed all appropriate conditions of a protocol. (CDISC)
Subject completion is when a clinical study participant ceases to be actively engaging in a clinical study because the participant has, or is presumed to have followed all appropriate conditions of a protocol. (CDISC)
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
